Offer - Urjas Oil for just ₹ 1
Nodon 10 Tablet (10) is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of High BP.
The optimal dosage of Nodon 10 Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Nodon 10 Tablet (10) as well, which are listed below. Usually, these side effects of Nodon 10 Tablet (10) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Nodon 10 Tablet (10)'s effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Nodon 10 Tablet (10)'s effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Nodon 10 Tablet (10) since this can cause severe adverse effects. Some other conditions that can be affected by Nodon 10 Tablet (10) are listed in the contraindications section below.
Drug interactions for Nodon 10 Tablet (10) have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Nodon 10 Tablet (10), it is important to know that it is not safe while driving, and is not habit-forming.
Nodon 10 Tablet (10) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Nodon 10 Tablet (10) safe for pregnant women?
Nodon has many dangerous side effects in pregnant women. If you are pregnant, do not consume Nodon without medical advice.
Is the use of Nodon 10 Tablet (10) safe during breastfeeding?
Nodon should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Nodon 10 Tablet (10) on the Kidneys?
Very few cases of side effects of Nodon on kidney have been reported.
What is the effect of Nodon 10 Tablet (10) on the Liver?
Very few cases of side effects of Nodon on the liver have been reported.
What is the effect of Nodon 10 Tablet (10) on the Heart?
Side effects of Nodon rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Nodon 10 Tablet (10) unless your doctor advises you to do so -
Is this Nodon 10 Tablet (10) habit forming or addictive?
Forming a habit of Nodon 10 Tablet (10) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nodon 10 Tablet (10) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Nodon 10 Tablet (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Nodon 10 Tablet (10) for mental disorders.
Interaction between Food and Nodon 10 Tablet (10)
When consumed with certain foods, Nodon 10 Tablet (10) may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Nodon 10 Tablet (10)
Consumption of alcohol and Nodon 10 Tablet (10) together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897
